Sirtex Medical Pty Ltd, commonly referred to as Sirtex, is a leading Australian biotechnology company headquartered in Sydney, Australia. Founded in 2000, Sirtex has established itself as a pioneer in the field of targeted cancer therapies, particularly through its innovative SIR-Spheres® microspheres, which deliver selective internal radiation therapy for liver cancer. With a strong presence in major operational regions including North America, Europe, and Asia, Sirtex is dedicated to improving patient outcomes through its unique approach to cancer treatment. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Sirtex continues to be recognised for its commitment to advancing cancer care, making it a notable player in the global oncology landscape.
We don't have data for Sirtex Medical Pty Ltd., but we can show you information about their parent organization instead.
View parent company